{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:06:24Z","timestamp":1779080784805,"version":"3.51.4"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose\/background<\/jats:title>\n                    <jats:p>Few studies have examined layer- and region-specific retinal thickness in relation to plasma Alzheimer\u2019s disease (AD) biomarkers in cognitively normal adults at increased risk for AD. We conducted an exploratory pilot study to examine whether thickness measurements of the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), and outer plexiform layer (OPL) were associated with plasma AD biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Spectral-domain optical coherence tomography was performed on 20 eyes from 11 cognitively normal participants enriched for AD risk using a low plasma A\u03b242\/40 ratio (&amp;lt;0.10). Retinal layers were segmented using a novel deep-learning algorithm, followed by manual review and refinement by trained graders when needed. Associations between retinal thickness and plasma neurofilament-light chain (NfL), glial fibrillary acidic protein (GFAP), A\u03b242\/40, p-tau217, and p-tau181 were evaluated using ridge regression with participant-level bootstrap resampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Exploratory relationships suggest that thinner INL and GCL measurements are associated with higher p-tau217 and GFAP levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Larger, longitudinal studies with confirmatory AD biomarker characterization are needed to validate these preliminary findings to determine how retinal OCT adds complementary value to plasma biomarkers for early AD risk assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1800287","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:18:03Z","timestamp":1779077883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inner retinal layer thickness reflects plasma biomarkers in preclinical Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Jane W.","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, David Geffen School of Medicine at UCLA","place":["Los Angeles, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Xu","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Abboud","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Alhasany","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Xu","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Analytical Biochemistry Core Laboratory, Huntington Medical Research Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Astraea","sequence":"additional","affiliation":[{"name":"Analytical Biochemistry Core Laboratory, Huntington Medical Research Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong Jewel","family":"Hu","sequence":"additional","affiliation":[{"name":"Doheny Image Analysis Laboratory, Doheny Eye Institute","place":["Pasadena, CA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3233\/JAD-231080","article-title":"The predictive ability of blood neurofilament light chain in predicting cognitive decline in the Alzheimer\u2019s disease continuum: a systematic review and meta-analysis","volume":"97","author":"Li","year":"2024","journal-title":"J Alzheimer's Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e11170","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain \u2013 from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dadm.2016.11.001","article-title":"The application of retinal fundus camera imaging in dementia: a systematic review","volume":"6","author":"McGrory","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41433-021-01648-1","article-title":"Optical coherence tomography angiography in Alzheimer's disease: a systematic review and meta-analysis","volume":"36","author":"Katsimpris","year":"2022","journal-title":"Eye (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","article-title":"Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings","volume":"136","author":"O'Bryhim","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acschemneuro.9b00331","article-title":"In vivo assessment of retinal biomarkers by hyperspectral imaging: early detection of Alzheimer's disease","volume":"10","author":"More","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","article-title":"Spectral-domain OCT measurements in Alzheimer's disease: a systematic review and meta-analysis","volume":"126","author":"Chan","year":"2019","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e002328","DOI":"10.1136\/bmjophth-2025-002328","article-title":"Retinal biomarkers for early Alzheimer's detection: a systematic review of optical coherence tomography (OCT) findings","volume":"11","author":"Lepoittevin","year":"2026","journal-title":"BMJ Open Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0236379","DOI":"10.1371\/journal.pone.0236379","article-title":"Retinal nerve fiber layer thickness predicts CSF amyloid\/tau before cognitive decline","volume":"15","author":"Asanad","year":"2020","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2021.0320","article-title":"Association of retinal changes with Alzheimer disease neuroimaging biomarkers in cognitively normal individuals","volume":"139","author":"Byun","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-022-00998-6","article-title":"The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals","volume":"14","author":"L\u00f3pez-de-Eguileta","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/WAD.0000000000000669","article-title":"Retinal and vascular findings in optical coherence tomography in healthy cognitive patients with Alzheimer disease biomarkers: a systematic review and meta-analysis","volume":"39","author":"Leal-Bernal","year":"2025","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231, and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/tvst.14.5.27","article-title":"Perifoveal choriocapillaris flow deficits associated with cerebrospinal fluid A\u03b242\/tau in presymptomatic Alzheimer's disease","volume":"14","author":"Chan","year":"2025","journal-title":"Transl Vis Sci Technol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.12977","article-title":"Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease","volume":"94","author":"Garc\u00eda-Mart\u00edn","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-180070","article-title":"Visualization of focal thinning of the ganglion cell-inner plexiform layer in patients with mild cognitive impairment and Alzheimer's disease","volume":"64","author":"Shao","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"fcae472","DOI":"10.1093\/braincomms\/fcae472","article-title":"Diagnosis of cognitive impairment and dementia: blood plasma and optical coherence tomography","volume":"7","author":"Jali","year":"2024","journal-title":"Brain Commun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e079861","DOI":"10.1002\/alz.079861","article-title":"Amyloid ratios in plasma and CSF are biomarkers of pre-symptomatic Alzheimer's disease","volume":"19","author":"Fonteh","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e79378","DOI":"10.1371\/journal.pone.0079378","article-title":"Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case-control study","volume":"8","author":"Harrington","year":"2013","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"011012","DOI":"10.1117\/1.NPh.4.1.011012","article-title":"Semiautomated segmentation and analysis of retinal layers in three-dimensional spectral-domain optical coherence tomography images of patients with atrophic age-related macular degeneration","volume":"4","author":"Hu","year":"2017","journal-title":"Neurophotonics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"076006","DOI":"10.1117\/1.JBO.18.7.076006","article-title":"Multiple layer segmentation and analysis in three-dimensional spectral-domain optical coherence tomography volume scans","volume":"18","author":"Hu","year":"2013","journal-title":"J Biomed Opt"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.65.2.1","article-title":"Potential structural biomarkers in 3D images validated by the first functional biomarker for early age-related macular degeneration \u2013 ALSTAR2 baseline","volume":"65","author":"Fasih-Ahmad","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.10.4.24","article-title":"Automatic segmentation in multiple OCT layers for Stargardt disease characterization via deep learning","volume":"10","author":"Mishra","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1214\/15-STS527","article-title":"High-dimensional inference: confidence intervals, p-values and R-software hdi","volume":"30","author":"Dezeure","year":"2015","journal-title":"Stat Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","article-title":"Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in the ganglion cell layer","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1167\/iovs.66.8.1195","article-title":"Retinal cell layer thickness is associated with GFAP in plasma and pTau181 in tear fluid","volume":"66","author":"Yarala","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1177\/13524585251360972","article-title":"Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis","volume":"31","author":"Krajnc","year":"2025","journal-title":"Mult Scler"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","article-title":"Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal\/parafoveal retina","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease","volume":"13","author":"Davis","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-022-02525-1","article-title":"Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies","volume":"145","author":"Hart de Ruyter","year":"2023","journal-title":"Acta Neuropathol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-024-01668-5","article-title":"Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease","volume":"17","author":"Ravichandran","year":"2025","journal-title":"Alzheimer's Res Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/jcm15010275","article-title":"Emerging oculomic signatures: linking thickness of entire retinal layers with plasma biomarkers in preclinical Alzheimer's disease","volume":"15","author":"Abboud","year":"2026","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"Palmqvist","year":"2015","journal-title":"Neurology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1800287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:18:04Z","timestamp":1779077884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1800287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1800287"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1800287","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1800287"}}